{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:20:59Z","timestamp":1747207259518,"version":"3.40.5"},"reference-count":38,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>We report the case of a 93-year-old patient with normal left ventricular function and severe mitral annulus calcification, with mild mitral steno-insufficiency.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation:<\/jats:title>\n<jats:p>She had developed creeping drugs-induced renal toxicity that is generally totally overlooked, due mainly to statins, a proton pump inhibitor, and aspirin. The Na and fluid retention, along with hypertension that ensued, although not severe, caused acute heart failure (sub-pulmonary edema) by worsening the mitral insufficiency. This occurred due to a less effi-cient calcific mitral annulus contraction during systole and an increasing mitral transvalvular gra-dient, as the transvalvular mitral gradient has an exponential relation to flow. After the suspension of the nephrotoxic drugs and starting intravenous furosemide, she rapidly improved. At 6 months follow-up, she is stable, in an NYHA 1-2 functional class, despite the only partial recovery of the renal function.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Progressive renal failure can functionally worsen even minimal mitral valvulopathy. Drug-induced nephrotoxicity can always be suspected in case of renal failure of unknown etiol-ogy. The suspension of the culprit drugs can improve renal function and dramatically improve the clinical symptoms even in a nonagenarian.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612828666220412093734","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:42:19Z","timestamp":1650001339000},"page":"970-977","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiorenal Syndrome Triggered by Slowly Progressive Drugs Toxicity-Induced\nRenal Failure along with Minimal Mitral Disease: A Case Report"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-575X","authenticated-orcid":true,"given":"Carlo","family":"Caiati","sequence":"first","affiliation":[{"name":"Department of Emergency and Organ Transplantation, Unit of Cardiovascular Diseases, University of Bari, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-7440","authenticated-orcid":true,"given":"Adriana","family":"Argentiero","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation, Unit of Cardiovascular Diseases, University of Bari, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9833-9576","authenticated-orcid":true,"given":"Stefano","family":"Favale","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation, Unit of Cardiovascular Diseases, University of Bari, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4391-6524","authenticated-orcid":true,"given":"Mario Erminio","family":"Lepera","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation, Unit of Cardiovascular Diseases, University of Bari, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"Roger V.L.","year":"2013","unstructured":"Roger V.L.; Epidemiology of heart failure. Circ Res 2013,113(6),646-659","journal-title":"Circ Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2478\/jtim-2018-0005","volume":"6","author":"Verdoodt A.","year":"2018","unstructured":"Verdoodt A.; Honore P.M.; Jacobs R.; De Waele E.; Van Gorp V.; De Regt J.; Spapen H.D.; Do statins induce or protect from acute kidney injury and chronic kidney disease: An update review in 2018. J Transl Int Med 2018,6(1),21-25","journal-title":"J Transl Int Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2215\/CJN.02050309","volume":"4","author":"Perazella M.A.","year":"2009","unstructured":"Perazella M.A.; Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 2009,4(7),1275-1283","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.ajkd.2009.10.046","volume":"55","author":"Perazella M.A.","year":"2010","unstructured":"Perazella M.A.; Toxic nephropathies: Core curriculum 2010. Am J Kidney Dis 2010,55(2),399-409","journal-title":"Am J Kidney Dis"},{"key":"ref=5","first-page":"457","volume":"7","author":"Pazhayattil G.S.","year":"2014","unstructured":"Pazhayattil G.S.; Shirali A.C.; Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis 2014,7,457-468","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"Rangaswami J.","year":"2019","unstructured":"Rangaswami J.; Bhalla V.; Blair J.E.A.; Chang T.I.; Costa S.; Lentine K.L.; Lerma E.V.; Mezue K.; Molitch M.; Mullens W.; Ronco C.; Tang W.H.W.; McCullough P.A.; Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the american heart association. Circulation 2019,139(16),e840-e878","journal-title":"Circulation"},{"key":"ref=7","author":"Rennke H.G.","year":"2014","unstructured":"Rennke H.G.; Bradley M.D.;  Renal Pathophysiology The essentials 2014","journal-title":"Renal Pathophysiology The essentials"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tcm.2019.07.011","volume":"30","author":"Massera D.","year":"2020","unstructured":"Massera D.; Kizer J.R.; Dweck M.R.; Mechanisms of mitral annular calcification. Trends Cardiovasc Med 2020,30(5),289-295","journal-title":"Trends Cardiovasc Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4103\/0019-5049.71043","volume":"54","author":"Kannan M.","year":"2010","unstructured":"Kannan M.; Vijayanand G.; Mitral stenosis and pregnancy: Current concepts in anaesthetic practice. Indian J Anaesth 2010,54(5),439-444","journal-title":"Indian J Anaesth"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/00365521.2012.746395","volume":"48","author":"L\u00f8drup A.B.","year":"2013","unstructured":"L\u00f8drup A.B.; Reimer C.; Bytzer P.; Systematic review: Symptoms of rebound acid hypersecretion following proton pump inhibitor treatment. Scand J Gastroenterol 2013,48(5),515-522","journal-title":"Scand J Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0952-3278(96)90014-9","volume":"54","author":"Bordia T.","year":"1996","unstructured":"Bordia T.; Mohammed N.; Thomson M.; Ali M.; An evaluation of garlic and onion as antithrombotic agents. Prostaglandins Leukot Essent Fatty Acids 1996,54(3),183-186","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/archinte.158.16.1743","volume":"158","author":"Rahman M.","year":"1998","unstructured":"Rahman M.; Smith M.C.; Chronic renal insufficiency: A diagnostic and therapeutic approach. Arch Intern Med 1998,158(16),1743-1752","journal-title":"Arch Intern Med"},{"key":"ref=13","first-page":"743","volume":"78","author":"Naughton C.A.","year":"2008","unstructured":"Naughton C.A.; Drug-induced nephrotoxicity. Am Fam Physician 2008,78(6),743-750","journal-title":"Am Fam Physician"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2174\/1871530319666191015191614","volume":"20","author":"Caiati C.","year":"2020","unstructured":"Caiati C.; Pollice P.; Favale S.; Lepera M.E.; The herbicide glyphosate and its apparently controversial effect on human health: An updated clinical perspective. Endocr Metab Immune Disord Drug Targets 2020,20(4),489-505","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0272-2712(18)30571-7","volume":"10","author":"Snyder J.W.","year":"1990","unstructured":"Snyder J.W.; Mechanisms of toxic cell injury. Clin Lab Med 1990,10(2),311-321","journal-title":"Clin Lab Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"Zanger U.M.","year":"2013","unstructured":"Zanger U.M.; Schwab M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013,138(1),103-141","journal-title":"Pharmacol Ther"},{"key":"ref=17","first-page":"1151","author":"Brenner B.M.","year":"1991","unstructured":"Brenner B.M.; Lazarus J.M.;  Harrison\u2019s\nprinciples of internal medicine 1991,1151-1157","journal-title":"Harrison\u2019s\nprinciples of internal medicine"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0140-6736(04)16513-6","volume":"363","author":"Wolfe S.M.","year":"2004","unstructured":"Wolfe S.M.; Dangers of rosuvastatin identified before and after FDA approval. Lancet 2004,363(9427),2189-2190","journal-title":"Lancet"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.amjcard.2015.11.031","volume":"117","author":"Acharya T.","year":"2016","unstructured":"Acharya T.; Huang J.; Tringali S.; Frei C.R.; Mortensen E.M.; Mansi I.A.; Statin use and the risk of kidney disease with long-term follow-up (8.4-Year Study). Am J Cardiol 2016,117(4),647-655","journal-title":"Am J Cardiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e000784","DOI":"10.1161\/JAHA.114.000784","volume":"3","author":"Sarma A.","year":"2014","unstructured":"Sarma A.; Cannon C.P.; de Lemos J.; Rouleau J.L.; Lewis E.F.; Guo J.; Mega J.L.; Sabatine M.S.; O\u2019Donoghue M.L.; The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome. J Am Heart Assoc 2014,3(3),e000784","journal-title":"J Am Heart Assoc"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"Baigent C.","year":"2011","unstructured":"Baigent C.; Landray M.J.; Reith C.; Emberson J.; Wheeler D.C.; Tomson C.; Wanner C.; Krane V.; Cass A.; Craig J.; Neal B.; Jiang L.; Hooi L.S.; Levin A.; Agodoa L.; Gaziano M.; Kasiske B.; Walker R.; Massy Z.A.; Feldt-Rasmussen B.; Krairittichai U.; Ophascharoensuk V.; Fellstr\u00f6m B.; Holdaas H.; Tesar V.; Wiecek A.; Grobbee D.; de Zeeuw D.; Gr\u00f6nhagen-Riska C.; Dasgupta T.; Lewis D.; Herrington W.; Mafham M.; Majoni W.; Wallendszus K.; Grimm R.; Pedersen T.; Tobert J.; Armitage J.; Baxter A.; Bray C.; Chen Y.; Chen Z.; Hill M.; Knott C.; Parish S.; Simpson D.; Sleight P.; Young A.; Collins R.; The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet SHARP Investigators2011,377(9784),2181-2192","journal-title":"Lancet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12882-019-1280-7","volume":"20","author":"Tonelli M.","year":"2019","unstructured":"Tonelli M.; Lloyd A.M.; Bello A.K.; James M.T.; Klarenbach S.W.; McAlister F.A.; Manns B.J.; Tsuyuki R.T.; Hemmelgarn B.R.; Alberta Kidney Disease Network. Statin use and the risk of acute kidney injury in older adults. BMC Nephrol 2019,20(1),103","journal-title":"BMC Nephrol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/ndt\/gfh474","volume":"19","author":"van Zyl-Smit R.","year":"2004","unstructured":"van Zyl-Smit R.; Firth J.C.; Duffield M.; Marais A.D.; Renal tubular toxicity of HMG-CoA reductase inhibitors. Nephrol Dial Transplant 2004,19(12),3176-3179","journal-title":"Nephrol Dial Transplant"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/0971-4065.136883","volume":"25","author":"Annigeri R.A.","year":"2015","unstructured":"Annigeri R.A.; Mani R.M.; Acute interstitial nephritis due to statin and its class effect. Indian J Nephrol 2015,25(1),54-56","journal-title":"Indian J Nephrol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0002-9343(03)00436-4","volume":"115","author":"Segal R.","year":"2003","unstructured":"Segal R.; Lubart E.; Leibovitz A.; Berkovitch M.; Habot B.; Yaron M.; Caspi D.; Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med 2003,115(6),462-466","journal-title":"Am J Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ph3072146","volume":"3","author":"Meek I.L.","year":"2010","unstructured":"Meek I.L.; Van de Laar M.A.F.J.; E. Vonkeman; H. Non-steroidal anti-inflammatory drugs: An overview of cardiovascular risks. Pharmaceuticals (Basel) 2010,3(7),2146-2162","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3390\/ph3072291","volume":"3","author":"H\u00f6rl W.H.","year":"2010","unstructured":"H\u00f6rl W.H.; Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals (Basel) 2010,3(7),2291-2321","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","volume":"176","author":"Schoenfeld A.J.","year":"2016","unstructured":"Schoenfeld A.J.; Grady D.; Adverse effects associated with proton pump inhibitors. JAMA Intern Med 2016,176(2),172-174","journal-title":"JAMA Intern Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"E5203","DOI":"10.3390\/ijms20205203","volume":"20","author":"Fossmark R.","year":"2019","unstructured":"Fossmark R.; Martinsen T.C.; Waldum H.L.; Adverse effects of proton pump inhibitors-evidence and plausibility. Int J Mol Sci 2019,20(20),E5203","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40620-016-0309-2","volume":"29","author":"Moledina D.G.","year":"2016","unstructured":"Moledina D.G.; Perazella M.A.; PPIs and kidney disease: From AIN to CKD. J Nephrol 2016,29(5),611-616","journal-title":"J Nephrol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/j.ajkd.2019.07.012","volume":"75","author":"Al-Aly Z.","year":"2020","unstructured":"Al-Aly Z.; Maddukuri G.; Xie Y.; Proton pump inhibitors and the kidney: Implications of current evidence for clinical practice and when and how to deprescribe. Am J Kidney Dis 2020,75(4),497-507","journal-title":"Am J Kidney Dis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11886-008-0071-8","volume":"10","author":"Griffin K.A.","year":"2008","unstructured":"Griffin K.A.; Bidani A.K.; Potential risks of calcium channel blockers in chronic kidney disease. Curr Cardiol Rep 2008,10(6),448-455","journal-title":"Curr Cardiol Rep"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000350377","volume":"37","author":"Sontrop J.M.","year":"2013","unstructured":"Sontrop J.M.; Dixon S.N.; Garg A.X.; Buendia-Jimenez I.; Dohein O.; Huang S.H.S.; Clark W.F.; Association between water intake, chronic kidney disease, and cardiovascular disease: A cross-sectional analysis of NHANES data. Am J Nephrol 2013,37(5),434-442","journal-title":"Am J Nephrol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/01.CIR.60.1.170","volume":"60","author":"Yoran C.","year":"1979","unstructured":"Yoran C.; Yellin E.L.; Becker R.M.; Gabbay S.; Frater R.W.; Sonnenblick E.H.; Dynamic aspects of acute mitral regurgitation: Effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 1979,60(1),170-176","journal-title":"Circulation"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/01.CIR.69.2.214","volume":"69","author":"Grose R.","year":"1984","unstructured":"Grose R.; Strain J.; Cohen M.V.; Pulmonary arterial V waves in mitral regurgitation: Clinical and experimental observations. Circulation 1984,69(2),214-222","journal-title":"Circulation"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0002-9149(87)91119-2","volume":"59","author":"Jawad I.A.","year":"1987","unstructured":"Jawad I.A.; Ghali M.H.; Brown R.L.; Sohn Y.H.; Pressure-flow relations across the normal mitral valve. Am J Cardiol 1987,59(8),915-918","journal-title":"Am J Cardiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1152\/ajplegacy.1969.216.6.1517","volume":"216","author":"Wathen R.L.","year":"1969","unstructured":"Wathen R.L.; Selkurt E.E.; Intrarenal regulatory factors of salt excretion during renal venous pressure elevation. Am J Physiol 1969,216(6),1517-1524","journal-title":"Am J Physiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"Mullens W.","year":"2009","unstructured":"Mullens W.; Abrahams Z.; Francis G.S.; Sokos G.; Taylor D.O.; Starling R.C.; Young J.B.; Tang W.H.W.; Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009,53(7),589-596","journal-title":"J Am Coll Cardiol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220412093734","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203431\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220412093734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:06:37Z","timestamp":1693238797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203431\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220412093734","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}